Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in Children With DIPG or H3K27+ Thalamic DMG
NCT02717455Phase 1Completed
- Sponsor
- Pediatric Brain Tumor Consortium
- Start
- Jun 2016
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of panobinostat in diffuse intrinsic pontine glioma (DIPG) and diffuse midline glioma (DMG), sponsored by Pediatric Brain Tumor Consortium. Started Jun 2016; status: completed.
02
Drugs
panobinostat
03
Conditions
diffuse intrinsic pontine glioma (DIPG)diffuse midline glioma (DMG)
Beyond the preview
Go deeper on NCT02717455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717455.